Ladone Mary Kay — SEC Form 4 filings
SEC reporting owner CIK 1760737. 14 Form 4 filings on record with FilingPulse; latest filed 2026-09-10.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-06-07 to 2026-09-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 3,908 shares, $98,464 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
- Largest priced transaction: sale of 3,908 shares @ $25.20 ($98,464) in KESTRA MEDICAL TECHNOLOGIES, LTD., filed 2026-09-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | Director | 2 | — | 1 leg · 3,908 sh · $98,464 | 2 |
| Bioventus Inc. (BVS) | Director | 5 | — | — | 11 |
| NOVANTA INC (NOVT) | Director | 4 | — | — | 7 |
| Inogen Inc (INGN) | Director | 3 | — | — | 3 |
Form 4 filings — Ladone Mary Kay
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-10 | 4 | KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | Sale (S): 3,908 @ $25.20 · Grant/award (A): 7,217 | EDGAR |
| 2026-06-09 | 4 | Inogen Inc (INGN) | Grant/award (A): 28,081 @ $0 | EDGAR |
| 2026-06-04 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 32,282 @ $0 · Option exercise (M): 32,282 (derivative) @ $0 · Grant/award (A): 25,146 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | NOVANTA INC (NOVT) | Option exercise (M): 1,325 · Option exercise (M): 1,325 (derivative) · Grant/award (A): 1,799 (derivative) @ $0 | EDGAR |
| 2025-09-08 | 4 | KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | Grant/award (A): 10,909 | EDGAR |
| 2025-07-14 | 4 | NOVANTA INC (NOVT) | Option exercise (M): 572 · Option exercise (M): 572 (derivative) | EDGAR |
| 2025-06-04 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 26,493 @ $0 · Option exercise (M): 26,493 (derivative) @ $0 · Grant/award (A): 32,282 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | Inogen Inc (INGN) | Grant/award (A): 30,612 @ $0 | EDGAR |
| 2025-01-06 | 4 | NOVANTA INC (NOVT) | Grant/award (A): 1,325 (derivative) @ $0 | EDGAR |
| 2024-07-15 | 4 | NOVANTA INC (NOVT) | Grant/award (A): 572 (derivative) | EDGAR |
| 2024-06-18 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 1,814 @ $0 · Option exercise (M): 1,814 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Bioventus Inc. (BVS) | Grant/award (A): 26,493 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 30,400 @ $0 · Option exercise (M): 30,400 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Inogen Inc (INGN) | Grant/award (A): 21,871 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1760737 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →